0001193125-26-197921.txt : 20260430 0001193125-26-197921.hdr.sgml : 20260430 20260430173048 ACCESSION NUMBER: 0001193125-26-197921 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20260430 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DBV Technologies S.A. CENTRAL INDEX KEY: 0001613780 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36697 FILM NUMBER: 26927479 BUSINESS ADDRESS: STREET 1: 107 AVENUE DE LA REPUBLIQUE CITY: CHATILLON STATE: I0 ZIP: 92320 BUSINESS PHONE: 33(0)155427878 MAIL ADDRESS: STREET 1: 107 AVENUE DE LA REPUBLIQUE CITY: CHATILLON STATE: I0 ZIP: 92320 8-K 1 d132063d8k.htm 8-K

8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

April 30, 2026

Date of Report (Date of earliest event reported)

DBV Technologies S.A.

(Exact name of registrant as specified in its charter)

France		001-36697		Not applicable
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

107 avenue de la République 92320 Châtillon France		Not Applicable
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +33 1 55 42 78 78

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Ordinary shares, nominal value €0.10 per share		n/a		The Nasdaq Stock Market LLC *
American Depositary Shares, each representing five ordinary shares, nominal value €0.10 per share		DBVT		The Nasdaq Stock Market LLC

* Not for trading, but only in connection with the registration of the American Depositary Shares on The Nasdaq Stock Market LLC.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition

On April 30, 2026, DBV Technologies S.A. (the “Company”) issued a press release announcing financial results and business highlights for the fiscal quarter ended March 31, 2026. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in Item 2.02 in this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit		Description
99.1		Press Release dated April 30, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

				DBV Technologies S.A.
Date: April 30, 2026				By:		/s/ Virginie Boucinha
				Name:		Virginie Boucinha
				Title:		Chief Financial Officer

EX-99.1 2 d132063dex991.htm EX-99.1

EX-99.1

Exhibit 99.1

Press Release Châtillon, France, April 30, 2026

DBV Technologies Reports First Quarter 2026 Financial Results

• Reported cash and cash equivalents of $229 million as of March 31, 2026 —providing funding into the second quarter of 2027 following the full exercise of the ABSA Warrants and BS Warrants issued in its March 2025 private placement (“PIPE”) financing

• Continued disciplined execution focused on BLA filing in the first half of this year and commercial preparedness for the U.S. launch of the VIASKIN^® Peanut Patch for children aged 4 to 7 years, if approved

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a late-stage biopharmaceutical company, today reported financial results for the first quarter of 2026. The quarterly and three months unaudited condensed financial statements were approved by the Board of Directors on April 30, 2026.

“The entire DBV team has been operating with exceptional focus and rigor as we progress towards significant milestones in the coming months, including the upcoming Biologics License Application (BLA) submissions for both our Children ages 4-7 and Toddler ages 1-3 programs in first half and second half of this year, respectively.” said Daniel Tassé, Chief Executive Officer of DBV Technologies. “We also plan to initiate a first of its kind study in infants ages 6 through 12 months. This Phase 2 study, previously announced at last year’s American College of Asthma, Allergy, and Immunology, and now called THRIVE, will assess the efficacy and safety of the VIASKIN^® Peanut Patch in achieving ad lib consumption of dietary peanut in peanut-allergic infants 6 through 12 months of age following a minimum of 3 years of treatment. Across all development programs, we are operating with extreme precision and purpose with the goal of providing practical, non-invasive treatment options to peanut allergy families no matter where they are on their treatment journey.”

Financial Highlights for the First Quarter Ended March 31, 2026

The Company’s interim unaudited condensed consolidated financial statements for the three months ended March 31, 2026, and the comparative period of March 31, 2025, are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).

In the first quarter of 2026, the Company started to execute its plan for growth, building on the key events from 2025, including the receipt of regulatory alignment with the U.S. Food and Drug Administration in the first quarter of 2025 regarding the safety data requirements and positive phase 3 clinical results in the fourth quarter, that will both support the planned BLA submission for the VIASKIN^® Peanut Patch in children aged 4 to 7 years in the first half of 2026.

Financial Performance

Operating Income

For the three months ended March 31, 2026, the Company accrued $1 million of French Research Tax Credit (“Crédit d’impôt recherche”). This level reflects the expected lower volume of eligible experimental activities on a full-year basis, as the Company’s focus continues to shift from clinical development toward commercial-readiness activities.

Research and Development Expenses

R&D expenses increased by $12 million for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, driven primarily by:

• Clinical-related expenses driven by the ongoing recruitment for the COMFORT Toddlers study, the VITESSE Open-label extension (OLE), and the acceleration of BLA-readiness activities.

• Investment in Medical Affairs, Quality and Regulatory functions in the United States.

• Continuous Pre-Commercial Inventory build-up in preparation for the launch of the VIASKIN^® Peanut Patch for children aged 4 to 7 years in the U.S., if approved.

Selling, General and Administrative (“SG&A”) Expenses

SG&A Expenses increased by $9 million for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, reflecting the Company’s steps towards building U.S. Commercial infrastructure. The Company plans a phased build of launch-readiness capabilities to support the U.S. launch of the VIASKIN^® Peanut Patch for children aged 4 to 7, if approved.

Net Loss

Net loss was $47.6 million for the three months ended March 31, 2026, compared to $27.1 million for the three months ended March 31, 2025. Net loss per share (based on the weighted average number of shares* over the period) decreased from $(0.26) to $(0.11) for the three months ended March 31, 2025, and March 31, 2026, respectively. This improvement reflects a significantly strengthened equity base following recent financings.

Cash Position and Liquidity

On March 31, 2026, the Company held $229 million in Cash and Cash Equivalents compared to $194 million of Cash and Cash Equivalents on December 31, 2025. Net cash used for operating activities was $49 million and $20 million for the periods ended March 31, 2026, and March 31, 2025, respectively. The Company’s net cash flows provided by financing activities totaled $89 million for the periods ended March 31, 2026, following the full exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 PIPE Financing.

Based on current operations, plans, and assumptions, management has determined that its Cash and Cash Equivalents are sufficient to fund its operations into the second quarter of 2027.

These estimates are based on the Company’s current forecasts and exclude any additional expenditures related to programs other than the VIASKIN Peanut or resulting from the potential in licensing or acquisition of additional product candidates or technologies, or any associated development the Company may pursue. The Company may have based these estimates on assumptions that are incorrect, and the Company may end up using its resources sooner than anticipated.

Unaudited condensed Consolidated Statement of Operations

(In millions of USD)		US GAAP Three months ended March 31
		2026				2025
Operating income			0.9				0.8
Operating expenses
Research and development expenses			(33.4	)			(21.5	)
Sales and marketing expenses			(4.8	)			(0.3	)
General and administrative expenses			(10.5	)			(5.6	)
Total Operating expenses			(48.8	)			(27.4	)
Loss from operations			(47.9	)			(26.6	)
Financial income (expense)			0.5				(0.5	)
Loss before taxes			(47.4	)			(27.1	)
Income tax			(0.2	)			—
Net loss			(47.6	)			(27.1	)
Basic/diluted Net loss per share attributable to shareholders*			(0.11	)			(0.26	)

* Following the March 2025 PIPE financing, this weighted-average share count includes the shares underlying the pre-funded warrants, as the remaining cash exercise price for those warrants is considered immaterial.

About DBV Technologies

DBV Technologies is a late-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with significant unmet medical need. DBV Technologies is currently focused on investigating the use of its proprietary VIASKIN^® patch technology to address food allergies, which are caused by a hypersensitive immune reaction and characterized by a range of symptoms varying in severity from mild to life-threatening anaphylaxis. Millions of people live with food allergies, including young children. Through epicutaneous immunotherapy (EPIT), the VIASKIN^® patch is designed to introduce microgram amounts of a biologically active compound to the immune system through intact skin. EPIT is a new class of non-invasive treatment that seeks to modify an individual’s underlying allergy by re-educating the immune system to become desensitized to allergen by leveraging the skin’s immune tolerizing properties. DBV Technologies is committed to transforming the care of food allergic people. The Company’s food allergy programs include ongoing clinical trials of the VIASKIN Peanut Patch in peanut allergic toddlers (1 through 3 years of age) and children (4 through 7 years of age).

DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, NJ. The Company’s ordinary shares are traded on segment B of Euronext Paris (DBV, ISIN code: FR0010417345) and the Company’s ADSs (each representing five ordinary shares) are traded on the Nasdaq Capital Market (DBVT – CUSIP: 23306J309).

For more information, please visit www.dbvtechnologies.com and engage with us on X (formerly Twitter) and LinkedIn.

Forward Looking Statements

This press release contains forward-looking statements, including, without limitation, statements regarding the Company’s financial condition, forecast of its cash runway, the therapeutic potential of Viaskin^® patch, designs of DBV’s anticipated clinical trials, including the planned Phase 2 THRIVE study in peanut-allergic infants aged 6 through 12 months, DBV’s planned regulatory and clinical efforts including timing and results of communications with regulatory agencies, clinical trial data releases and publications, the potential regulatory submissions, regulatory approval, launch and commercialization of the Company’s product candidates, the ability of any of DBV’s product candidates, if approved, to improve the lives of patients with food allergies, and the Company’s business strategy and

goals. These forward-looking statements and estimates are not promises or guarantees and involve substantial risks and uncertainties. At this stage, the Company’s product candidates have not been authorized for sale in any country. Among the factors that could cause actual results to differ materially from those described or projected herein include uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals, the Company’s ability to successfully execute on its growth plans, commercial readiness activities and BLA-related efforts, risks related to the commercialization and launch of the Company’s product candidates, including market acceptance, pricing and reimbursement, and the Company’s ability to obtain additional financing on acceptable terms, if needed, to fund its operations. A further list and description of risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements in this press release can be found in DBV’s regulatory filings with the U.S. Securities and Exchange Commission (“SEC”), including in DBV’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 26, 2026, as amended by the Amendment No. 1 on Form 10-K/A filed with the SEC on April 30, 2026, and future filings and reports made with the SEC by DBV. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date hereof. Other than as required by applicable law, DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release.

VIASKIN is a registered trademark of DBV Technologies.

Investor Contact

Jonathan Neely

DBV Technologies

Jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

DBV Technologies

Brett.whelan@dbv-technologies.com

EX-101.SCH 3 dbvt-20260430.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 4 dbvt-20260430_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 dbvt-20260430_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock [Member] Common Stock [Member] ADR [Member] ADR [Member] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line Entity Emerging Growth Company Entity Emerging Growth Company Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Entity Address Postal Zip Code Entity Address Postal Zip Code Entity Address City Or Town Entity Address City Or Town Entity Address Country Entity Address Country Country Region Country Region City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title No Trading Symbol Flag No Trading Symbol Flag Security Exchange Name Security Exchange Name Trading Symbol Trading Symbol Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag EX-101.PRE 6 dbvt-20260430_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 g132063g09j51.jpg GRAPHIC begin 644 g132063g09j51.jpg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g132063g24g56.jpg GRAPHIC begin 644 g132063g24g56.jpg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end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.26.1

Document and Entity Information	Apr. 30, 2026
Document And Entity Information [Line Items]
Document Type	8-K
Document Period End Date	Apr. 30, 2026
Entity Registrant Name	DBV Technologies S.A
Entity Incorporation State Country Code	I0
Entity File Number	001-36697
Entity Tax Identification Number	00-0000000
Entity Address Address Line	107 avenue de la République
Entity Address Postal Zip Code	92320
Entity Address City Or Town	Châtillon
Entity Address Country	FR
Country Region	33
City Area Code	1
Local Phone Number	55 42 78 78
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Entity Central Index Key	0001613780
Amendment Flag	false
Common Stock [Member]
Document And Entity Information [Line Items]
Security 12b Title	Ordinary shares, nominal value €0.10 per share
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
ADR [Member]
Document And Entity Information [Line Items]
Security 12b Title	American Depositary Shares, each representing five ordinary shares, nominal value €0.10 per share
Security Exchange Name	NASDAQ
Trading Symbol	DBVT

X

- References

No definition available.

+ Details

Name:	dbvt_DocumentAndEntityInformationLineItems
Namespace Prefix:	dbvt_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:	dei_AmendmentFlag
Namespace Prefix:	dei_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:	dei_CityAreaCode
Namespace Prefix:	dei_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Region code of country

+ References

No definition available.

+ Details

Name:	dei_CountryRegion
Namespace Prefix:	dei_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:	dei_DocumentPeriodEndDate
Namespace Prefix:	dei_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:	dei_DocumentType
Namespace Prefix:	dei_
Data Type:	dei:submissionTypeItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:	dei_EntityAddressAddressLine1
Namespace Prefix:	dei_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:	dei_EntityAddressCityOrTown
Namespace Prefix:	dei_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

ISO 3166-1 alpha-2 country code.

+ References

No definition available.

+ Details

Name:	dei_EntityAddressCountry
Namespace Prefix:	dei_
Data Type:	dei:countryCodeItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:	dei_EntityAddressPostalZipCode
Namespace Prefix:	dei_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2

+ Details

Name:	dei_EntityCentralIndexKey
Namespace Prefix:	dei_
Data Type:	dei:centralIndexKeyItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2

+ Details

Name:	dei_EntityEmergingGrowthCompany
Namespace Prefix:	dei_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:	dei_EntityFileNumber
Namespace Prefix:	dei_
Data Type:	dei:fileNumberItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:	dei_EntityIncorporationStateCountryCode
Namespace Prefix:	dei_
Data Type:	dei:edgarStateCountryItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2

+ Details

Name:	dei_EntityRegistrantName
Namespace Prefix:	dei_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2

+ Details

Name:	dei_EntityTaxIdentificationNumber
Namespace Prefix:	dei_
Data Type:	dei:employerIdItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:	dei_LocalPhoneNumber
Namespace Prefix:	dei_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Boolean flag that is true only for a security having no trading symbol.

+ References

No definition available.

+ Details

Name:	dei_NoTradingSymbolFlag
Namespace Prefix:	dei_
Data Type:	dei:trueItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c

+ Details

Name:	dei_PreCommencementIssuerTenderOffer
Namespace Prefix:	dei_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b

+ Details

Name:	dei_PreCommencementTenderOffer
Namespace Prefix:	dei_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b

+ Details

Name:	dei_Security12bTitle
Namespace Prefix:	dei_
Data Type:	dei:securityTitleItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1

+ Details

Name:	dei_SecurityExchangeName
Namespace Prefix:	dei_
Data Type:	dei:edgarExchangeCodeItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12

+ Details

Name:	dei_SolicitingMaterial
Namespace Prefix:	dei_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:	dei_TradingSymbol
Namespace Prefix:	dei_
Data Type:	dei:tradingSymbolItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425

+ Details

Name:	dei_WrittenCommunications
Namespace Prefix:	dei_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=dei_AdrMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 3 24 1 false 2 0 false 0 false false R1.htm 000001 - Document - Document and Entity Information Sheet http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d132063d8k.htm dbvt-20260430.xsd dbvt-20260430_def.xml dbvt-20260430_lab.xml dbvt-20260430_pre.xml http://xbrl.sec.gov/dei/2025 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d132063d8k.htm": { "nsprefix": "dbvt", "nsuri": "http://www.dbv-technologies.com/20260430", "dts": { "inline": { "local": [ "d132063d8k.htm" ] }, "schema": { "local": [ "dbvt-20260430.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "definitionLink": { "local": [ "dbvt-20260430_def.xml" ] }, "labelLink": { "local": [ "dbvt-20260430_lab.xml" ] }, "presentationLink": { "local": [ "dbvt-20260430_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2025": 4 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 31, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2025": 26 }, "report": { "R1": { "role": "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "000001 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2026-04-30_to_2026-04-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d132063d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2026-04-30_to_2026-04-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d132063d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AdrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AdrMember", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ADR [Member]", "terseLabel": "ADR [Member]", "documentation": "American Depositary Receipt (or American Depositary Share, ADS)." } } }, "auth_ref": [ "r6" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockDomain", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CountryRegion", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Country Region", "terseLabel": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dbvt_DocumentAndEntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.dbv-technologies.com/20260430", "localname": "DocumentAndEntityInformationLineItems", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "auth_ref": [] }, "dbvt_DocumentAndEntityInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://www.dbv-technologies.com/20260430", "localname": "DocumentAndEntityInformationTable", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "terseLabel": "Entity Address Address Line", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "terseLabel": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Country", "terseLabel": "Entity Address Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoTradingSymbolFlag", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "terseLabel": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://www.dbv-technologies.com//20260430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r7" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d-3" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001193125-26-197921-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-26-197921-xbrl.zip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end XML 18 d132063d8k_htm.xml IDEA: XBRL DOCUMENT 0001613780 2026-04-30 2026-04-30 0001613780 us-gaap:CommonStockMember 2026-04-30 2026-04-30 0001613780 dei:AdrMember 2026-04-30 2026-04-30 00-0000000 true 0001613780 false 8-K 2026-04-30 DBV Technologies S.A I0 001-36697 107 avenue de la République 92320 Châtillon FR 33 1 55 42 78 78 false false false false Ordinary shares, nominal value €0.10 per share NASDAQ American Depositary Shares, each representing five ordinary shares, nominal value €0.10 per share DBVT NASDAQ false